ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Abroad (travel likely)Recruiting

Conditions

Chronic Spontaneous Urticaria (CSU) · Allergic Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Montpellier, Montpellier, France
Contact: Study coordinator (Arnaud Bourdin, MD, PhD) · a-bourdin@chu-montpellier.fr · +33 4 67 33 60 96

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria

Chronic Spontaneous Urticaria · Chronic Urticaria, Idiopathic

Abroad (travel likely)RecruitingPHASE4

Copenhagen, Denmark

Trial of JYB1904 in Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)

Abroad (travel likely)RecruitingPHASE2

North Miami Beach, United States · Glenview, United States

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Chronic Spontaneous Urticaria (CSU)

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States